Correlation Between Takeda Pharmaceutical and INDOSAT B

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and INDOSAT B at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and INDOSAT B into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical and INDOSAT B , you can compare the effects of market volatilities on Takeda Pharmaceutical and INDOSAT B and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of INDOSAT B. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and INDOSAT B.

Diversification Opportunities for Takeda Pharmaceutical and INDOSAT B

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Takeda and INDOSAT is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and INDOSAT B in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INDOSAT B and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with INDOSAT B. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INDOSAT B has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and INDOSAT B go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and INDOSAT B

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to under-perform the INDOSAT B. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical is 2.88 times less risky than INDOSAT B. The stock trades about -0.01 of its potential returns per unit of risk. The INDOSAT B is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  8.75  in INDOSAT B on September 16, 2024 and sell it today you would earn a total of  5.25  from holding INDOSAT B or generate 60.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.21%
ValuesDaily Returns

Takeda Pharmaceutical  vs.  INDOSAT B

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
INDOSAT B 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INDOSAT B has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, INDOSAT B is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Takeda Pharmaceutical and INDOSAT B Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and INDOSAT B

The main advantage of trading using opposite Takeda Pharmaceutical and INDOSAT B positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, INDOSAT B can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INDOSAT B will offset losses from the drop in INDOSAT B's long position.
The idea behind Takeda Pharmaceutical and INDOSAT B pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments